Jerry Stringham has invested much of the past fourteen years as a reimbursement strategy consultant.  Beginning in December 1988, Mr. Stringham began providing reimbursement consulting to diverse medical and pharmaceutical companies.  Mr. Stringham has a BS in Mechanical Engineering from the Massachusetts Institute of Technology and an MBA from Harvard Business School.  He has been part of five medical device start-up organizations operating out of New England.  Mr. Stringham also served for a year as a Principal in the reimbursement consulting practice of a major CRO, where he managed over 40 engagements representing over $800,000 in reimbursement projects.

Advisory Board Members:

Paul Valentine  is President and Chief Executive Officer of Sleep HealthCenters (SHC), a sleep medicine company with facilities in Eastern Massachusetts.  In Paul’s first year with SHC, the company grew 40% and turned its first profit.  Prior to SHC, Paul was President of Children’s Medical Ventures (ChMV), a division of Novametrix Medical Systems, which was sold to Respironics in April 2002.  ChMV is a developer and marketer of neonatal products and services.  Under Paul’s tenure, ChMV sales doubled, while operating margin tripled, contributing to the sale of ChMV and Novametrix.  Over the past 15 years Paul has held senior management positions at five fast–growing companies in four different industries, including positions at SHC and ChMV, Chief Financial Officer and Treasurer at Cape Cod Potato Chips, and CFO at Boston Popcorn.  Paul brings a broad background in all aspects of managing small to mid-size companies including finance, sales, marketing, operations, and product development.  He was named as one of the Boston area’s top 40 business people under the age of 40 in 2003 by the Boston Business Journal.  Paul has a B.S. in Accounting and a MBA, both from Babson College.

Karen Wilson brings a wealth of clinical and marketing experience to Blue Torch.  Ms. Wilson is a former Vice President of Marketing and Sales for Fresenius Healthcare, a company that manufactures and sells dialysis supplies and services to end stage renal disease patients.  Fresenius grew from a start-up company to having annual sales in excess of $100 million in her seven years with the company.  After Fresenius, Ms. Wilson was Senior Vice President of Marketing and Sales at Vasca, Inc., where she built a 60-person clinical, sales and marketing organization for this venture backed, start-up company that provides a novel organ access system, primarily for dialysis patients.